A clinical formulation indicated for Antibiotics. Supports the eradication of bacterial pathogens within the urinary tract and aids in the resolution of associated discomfort.
A urinary-specific antibiotic developed to manage bladder infections and designed to alleviate UTI symptoms by targeting bacterial proteins and DNA.
Mechanism of Action
It is reduced by bacterial enzymes into reactive intermediates. These intermediates attack bacterial ribosomes, DNA, and metabolic enzymes, killing the bacteria in the urine.
Route of Administration
Oral
Onset Time
24–48 hours
Duration
6–12 hours
Contraindications
Severe kidney disease, End of pregnancy (38–42 weeks), Infants under 1 month, Lack of urination (Anuria)
Information for Nitrofurantoin is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
